CPL - Chalmers Publication Library
| Utbildning | Forskning | Styrkeområden | Om Chalmers | In English In English Ej inloggad.

Assessing the human gut microbiota in metabolic diseases.

Fredrik H. Karlsson (Institutionen för kemi- och bioteknik, Systembiologi) ; Valentina Tremaroli ; Jens B. Nielsen (Institutionen för kemi- och bioteknik, Systembiologi) ; Fredrik Bäckhed
Diabetes (1939-327X). Vol. 62 (2013), 10, p. 3341-9.
[Artikel, refereegranskad vetenskaplig]

Recent findings have demonstrated that the gut microbiome complements our human genome with at least 100-fold more genes. In contrast to our Homo sapiens-derived genes, the microbiome is much more plastic, and its composition changes with age and diet, among other factors. An altered gut microbiota has been associated with several diseases, including obesity and diabetes, but the mechanisms involved remain elusive. Here we discuss factors that affect the gut microbiome, how the gut microbiome may contribute to metabolic diseases, and how to study the gut microbiome. Next-generation sequencing and development of software packages have led to the development of large-scale sequencing efforts to catalog the human microbiome. Furthermore, the use of genetically engineered gnotobiotic mouse models may increase our understanding of mechanisms by which the gut microbiome modulates host metabolism. A combination of classical microbiology, sequencing, and animal experiments may provide further insights into how the gut microbiota affect host metabolism and physiology.

Denna post skapades 2013-12-06. Senast ändrad 2015-11-24.
CPL Pubid: 188514


Läs direkt!

Länk till annan sajt (kan kräva inloggning)

Institutioner (Chalmers)

Institutionen för kemi- och bioteknik, Systembiologi (2008-2014)
Institutionen för medicin, avdelningen för molekylär och klinisk medicin (GU)
Wallenberglaboratoriet (GU)


Medicinska grundvetenskaper

Chalmers infrastruktur

C3SE/SNIC (Chalmers Centre for Computational Science and Engineering)

Relaterade publikationer

Denna publikation ingår i:

Systems Biology of the Gut Microbiome in Metabolic Diseases